🟢 Sunshine Biopharma is trading 8.35% up in pre-market with no clear catalyst identified

Sunshine Biopharma is trading at $2.97, up 8.35% in pre-market, with the cause of the November 4, 2026 rise unclear.

• No clear company-specific announcement or catalyst for the rise was identified.
• The latest company release found was the October 22 reverse stock split announcement, which predates the move.
• Market context is mixed and does not establish a broader-market explanation.